Viewing Study NCT01611259

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:46 PM
Ignite Modification Date: 2025-12-26 @ 1:17 PM
Study NCT ID: NCT01611259
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2012-05-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MALT Lymphoma View
None Lenalidomide View
None Rituximab View
None AGMT View